Article
Urinary Modified C-Reactive Protein is Closely Associated with Tubulointerstitial Lesions…
Mediators of Inflammation · 2022 · Mo Yuan, author Xiao-ling Liu, author Ying Tan, author Feng Yu, author Ming-hui Zhao, author Shin-ichi Yokota, Academic Editor
Key facts
| Title | Urinary Modified C-Reactive Protein is Closely Associated with Tubulointerstitial Lesions in Lupus Nephritis |
|---|---|
| First author | Mo Yuan, author Xiao-ling Liu, author Ying Tan, author Feng Yu, author Ming-hui Zhao, author Shin-ichi Yokota, Academic Editor |
| Journal | Mediators of Inflammation |
| Published | Jun 2, 2022 |
| DOI | 10.1155/2023/6107911 |
| Devices mentioned | K000121, K010236, K024210, K051564, K060130, K071002, K073489, K073490, K130122, K822496, K852441, K854177 and 18 more |
| Product codes mentioned | CDT, CEO, CFN, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, CZP and 37 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1